Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Procedue Conducted by Type & End-users The global spinal non-fusion devices market will witness a robust CAGR of 5.1%, valued at $3.88 billion in 2021, expected to appreciate and reach $6.08 billion by 2030, confirms Strategic Market Research. Spinal implants are medical devices used to address spinal diseases such as disproportion and instability. According to the Spinal Injury Association UK, around 2,500 people are wounded or diagnosed each year with spinal cord injuries in the UK. An estimated 50,000 people live with spinal cord injuries. Fusion and non-fusion devices are the two types of spine surgical equipment. Non-fusion devices are used in the treatment by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating them. Fusion devices heal by providing immediate and rigid immobilization. The advent of Novel Non-Fusion and Fusion approaches have improvised the overall surgical outcomes for the patients suffering from spinal injuries. The newly discovered Non Fusion technologies came up with a way of effectively treating the adolescents suffering from scoliosis. VBT or Vertebral Body Tethering technology developed by the spinal specialists are showing great results in the treatment of adolescent idiopathic scoliosis by circumventing the various obstacles associated with the fusion process. Moreover, this new VBT technique inculcates a procedure known as growth modulation. It adequately corrects the spinal curvature for continuing it’s straightening. During the conduction of this process, the titanium screws are installed on one side of the spine that has an outward curvature and is fitted with a flexible cord on the other side. When some force is exerted on the cord, it compresses both the adjacent screws for keeping the spine upright. A research study conducted by SMR revealed that the demand for VBT is rising at an exponential rate since it received its FDA approval back in August 2019. Moreover, the process is found out to be more time-effective and it takes hardly 5 to 6 hours for performing the surgery by using this technique. Key Industry Drivers - Rising Geriatric Population, Increasing Spinal Disorders For people over the age of 50, spinal problems such as Spinal-Stenosis are one of the common prevalent conditions. The adults, especially who are suffering from comorbidities & reduced immunity, are more prone to various kinds of spinal disorders. Due to the introduction of highly advanced spine fusion & gadgets, the overall preference for the spine level therapies are expanding extensively. Furthermore, the usage of these type of implants & devices is regarded as highly successful and most recommended kind of treatments for spinal abnormalities. According to the CDC, spinal abnormalities afflicted 34.0 per cent of adults and 62.0 per cent of the elderly in 2019. Trauma, falls, crashes, and road traffic accidents are the most leading causes of spinal fusion injuries. Due to a growth in the frequency of spinal abnormalities & increased healthcare spending, Asia-Pacific has a large market for the Spinal Fusion Devices. Furthermore, the rapidly ageing population, as well as the lower cost of spinal surgeries in developing nations like India compared to industrialized countries like the United States, has raised the demand for spinal implants. In India, nearly 2,000 hospitals do spinal surgery, including at least 500 multi-faculty spinal surgery facilities and super-speciality hospitals performing intricate and advanced surgeries like microscopic spine surgery. As a result of the aforementioned issues, demand for spinal fusion devices is expected to increase. Restraints - Impact of Covid 19 The global COVID-19 pandemic and lockdown situation in some countries have revealed some challenges in the spinal non-fusion devices market, owing to a moratorium on orthopaedic services by hospitals and clinics to prevent the spread of the COVID-19 virus, as well as tremendous pressure on hospitals to provide services to COVID-19 patients. According to an article published by Annals of Medicine and Surgery, an estimate of the orthopaedic surgery cancellation rate was roughly 82.0 percent representing 6.2 million of 7.6 million cases. Opportunities - Focus on Minimally Invasive Surgeries The growing popularity of MIS (minimally invasive surgery) is driving up demand for spinal fusion devices. Surgeons prefer MIS as compared to an open surgery because of different reasons, along with less discomfort, a quicker recovery period, & lowering the risk of tissue damage. Plethora of bone issues are treated with minimally invasive methods. Nearly 400k spinal fusion processes are carried out in the United States every year, thereby making it as the most common & highly efficient treatment options for a wide range of bone degenerative disorders, spine trauma and structural defects. Spinal Non-Fusion Devices Market Analysis Of Different Segments Covered in the Report Based on the Type Artificial disc replacement device Partial disc (nucleus) replacement device Dynamic stabilization devices Total disc replacement devices Annulus repair device Based on the End-User Hospitals Speciality Clinics Regional Coverage Analysis North America Mexico Canada US Rest of North America Europe Germany France Italy Spain Uk Rest of Europe Asia Pacific Japan India China Australia Rest of APAC LAMEA South Africa Saudi Arabia Brazil Rest of LAMEA Segments Analysis & Insights Based on Type, Dynamic Stabilization Devices held the largest spinal non-fusion devices market share in 2020. Interspinous process spacers, Pedicle screw-based systems , and facet replacement items are among the devices which are available. The adoption of stiff spinal implants for fusion technologies is responsible for the segment's dominance. Furthermore, the increased prevalence of spinal degenerative disc diseases contributes significantly to the segment's expansion. Furthermore, technical breakthroughs that result in changes in therapeutic processes, such as biochemical enhancements and the adoption of BioFlex systems, are projected to drive the segment's expansion. Lower back discomfort and radicular leg pain are common symptoms of lumbar disc herniation. According to the journal Scoliosis and Spinal Disorders, between 60 and 85 percent of the population had lower back discomfort. Non-fusion surgery is a procedure that can be used to treat spinal degenerative disorders. As a result, this aspect is projected to drive demand for dynamic stabilization devices in the market under consideration. In the End-user segment, Hospitals segment held the maximum share in 2020. This is due to favourable health reimbursement regulations for spinal surgeries and the widespread use of spine navigation software. According to the journal Neurosurgery, spinal surgery performed at ambulatory surgery centres can save USD 140 million each year. In the Regions segment, North America held the maximum share in 2020. The rise of the spinal surgery market in the United States has been aided by technological advancements, senior patients anticipating improved levels of function, and reimbursement arrangements that encourage advanced fusion surgery. According to the (NSCIS) National Spinal Cord Injury Statistical Centre’s 2019 SCI Datasheet, the annual incidence of spinal cord injury (SCI) in the United States is around 54 instances per one million individuals, or about 17,810 new SCI-related cases each year. Spinal Non-Fusion Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 3.88 Billion Revenue forecast in 2030 USD 6.08 Billion Growth rate CAGR of approximately 5.1% Base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By End-user, By Region By Type Artificial disc replacement device, Partial disc (nucleus) replacement device, Dynamic stabilization devices, Total Facet replacement devices, Annulus repair device By End-user Hospitals, Speciality Clinics By Region Asia Pacific, North America, Europe, LAMEA Country Scope Canada, France, US Germany, U.K., India, Japan, China, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles DePuy Synthes, Stryker Corporation, Medtronic, Globus Medical, Inc, LLC, and Zimmer Biomet Holdings, Inc, Paradigm Spine, NuVasive, Inc, Global Spinal Non-Fusion Devices Market Competitive Landscape Analysis The competitive landscape overview divulges information about the prevailing competitors operating at a global level. The comparison is performed and conducted based on overall revenue generation, key investments by the venture capitalists, Go to market strategies, market initiatives, company overview, SWOT Analysis, investment in R&D, company weaknesses and strengths, company financials , global presence, production capacity, PESTLE Analysis, market potential, etc. Medtronic Stryker Corporation DePuy Synthes LLC Globus Medical, Inc. Zimmer Biomet Holdings, Inc. NuVasive, Inc. Paradigm Spine Recent Developments On June 2022 Aurora Spine Corporation which is a manufacturer and designer of new and innovative medical devices that ameliorates spinal surgery outcomes, announced the issuance of US Patent No: 11,331,199 entitled “Spinal Implant for Motion Preservation or Fusion.” The patent covers Aurora’s ZIPFlex Technology for a MI posterior interlaminar implant for motion preservation that could be adapted into a non-fusion or fusion device while implanted in a patient through a small modular attachment On June 2022 Theradaptive, which is a private biopharmaceutical company which is leading a new class of regenerative implants clearly announced that the U.S (FDA) has granted the breakthrough medical device designation for the usage of OsteoAdapt SP in case of Anterior Lumbar-Interbody Fusion. This is regarded as the 3rd Breakthrough Designation for Theradaptive spinal-fusion coupled with the transforaminal interbodies & posterolateral fusion, which will allow it in addressing more than 90 percent of the overall lumbar spinal fusion procedure. On June 2022 Altus Spine, one of the industry leaders in the innovation & development of medical devices which is effectively used in spinal correction surgery, announced the FDA 510(K) clearance of its Sochi OCT System. Sochi OCT System delivers a seamless transition from sacrum to occiput. The Sochi OCT System consists of polyaxial screws, rods, hooks, locking screw connectors and assemblies which may be locked together in a plethora of configurations to propel and promote fusion for large number of patient anatomies. On June 2022 the announcement made by 3Spine regarding the US (FDA) investigational device exemption approval for a US pivotal clinical trial for the purpose of their MOTUS spinal implant. The MOTUS device, the implant used in the Balanced Back total joint replacement procedure, is the first of its kind technology that replaces the function of the facet and disc joints following a posterior approach. On June 2022 Zavation Medical declared that it had successfully received an FDA approval for the launching of its unique eZspand Lateral-Expandable Lumbar-Interbody-Fusion System. Zavation has adequately designed & curated the eZspand lateral, which is indeed a pivotal part of the eZspand interbody fusion device, along with an absolute precision and expansion to deliver an optimum fit in case of each & every patient, thereby allowing the improvisation of sagittal balance & structural stability. In February 2021, LimiFlex with decompression for patients with degenerative spondylolisthesis and lumbar spinal stenosis has begun the PMA filing procedure, according to Empirical Spine Inc. In December 2020, Alphatec has agreed to purchase EOS imaging, S.A., a company known for its biplanar whole-body imaging and 3D modelling capabilities. The ultimate objective of this acquisition is to increase inventory efficiency and expand the product portfolio. In September 2020, Spineology Inc. has received FDA approval for its OptiMesh Expandable Interbody Fusion System, which is a patented Spineology Interbody Fusion System. In May 2020, The US FDA (Food and Drug Administration) have granted 4WEB Medical 510(k) permission to commercialize its Stand-Alone Anterior Interbody cages. The industry is growing because of the rising acceptance rates of minimally invasive treatments such as transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF). Frequently Asked Question About This Report What is the spinal non-fusion devices market growth? The global spinal non-fusion devices market is expected to grow at a compound annual growth rate (CAGR) of 5.1% from 2021 to 2030 to reach USD6.08 billion by 2030. How big is the spinal non-fusion devices market? The global spinal non-fusion devices market size was $3.88 Bn in 2021 and is predicted to reach $6.08 Bn by 2030, with a CAGR of 5.1%. Which region has the largest share in the market? In the Regions segment, North america held the maximum market share in 2020. The rise of the spinal surgery market in the United States has been aided by technological advancements, senior patients anticipating improved levels of function, and reimbursement arrangements that encourage advanced fusion surgery. According to the (NSCIS) National Spinal Cord Injury Statistical Centre’s 2019 SCI Datasheet, the annual incidence of spinal cord injury (SCI) in the United States is around 54 instances per one million individuals, or about 17,810 new SCI-related cases each year. What is the study period forecasted for this market? The global spinal non-Fusion market is studied from 2020 to 2030. What is the compounded annual growth rate of spinal non-fusion devices market? It is expected to expand at 5.1% CAGR from 2020 to 2030. Who are all the key players operating in the market? Medtronic, Stryker Corporation, NuVasive, Inc., DePuy Synthes , Globus Medical, Inc., Paradigm Spine, and Zimmer Biomet Holdings, Inc, LLC. Is TMS used for TBI? Based on the success of TMS and other non-invasive brain stimulation techniques in altering brain activity, TMS has been proposed as a potential treatment for adult TBI. What are the types of TBI (traumatic brain injuries)? Concussions, contusions, penetrating injuries, anoxic brain injuries are the 4 types of TBIs. Sources https://www.spinal.co.uk/news/spinal-cord-injury-paralyses-someone-every-four-hours-new-estimates-reveal/ https://www.cdc.gov/ncbddd/birthdefects/facts-about-neural-tube-defects.html https://lww.com/pages/default.aspx https://scoliosisjournal.biomedcentral.com/articles/10.1186/s13013-016-0086-7 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Spinal Non-Fusion Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Spinal Non-Fusion Devices Market 4.2.1 Market, 2021-2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021-2030 (USD Million) 4.4 Type Business Analysis 4.4.1 Market, By Type, 2021-2030 (USD Million) 4.5 End-User Business Analysis 4.5.1 Market, By End-User, 2021-2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-User Analysis 5.11.1. Trends in End-User (2014-2020) 5.11.2. Trends in End-User (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Facial Implants Manufacturing Sites, Area Served, Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Artificial disc replacement device 7.3.1. Artificial disc replacement device market, 2021-2030 (USD Million) 7.4. Partial disc (nucleus) replacement device 7.4.1. Partial disc (nucleus) replacement device market, 2021-2030 (USD Million) 7.5. Dynamic stabilization devices 7.5.1. Dynamic stabilization devices market, 2021-2030 (USD Million) 7.6. Total disc replacement devices 7.6.1. Total disc replacement devices market, 2021-2030 (USD Million) 7.7. Annulus repair device 7.7.1. Annulus repair device market, 2021-2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Speciality Clinics 8.4.1. Speciality Clinics market, 2021-2030 (USD Million) 9. Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By Type, 2021-2030 (USD Million) 9.1.4. North America Market, By End-User, 2021-2030 (USD Million) 9.1.5. North America Market, by Country, 2021-2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By Type, 2021-2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By Type, 2021-2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021-2030 (USD Million) 9.1.4.2.3. Canada Market, By End-Users, 2021-2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By Type, 2021-2030 (USD Million) 9.2.2. Europe Market, by By End-User, 2021-2030 (USD Million) 9.2.5. Europe Market, by country, 2021-2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By Type, 2021-2030 (USD Million) 9.2.4.1.2. U.K. Market, By End-Users, 2021-2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021-2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By Type, 2021-2030 (USD Million) 9.2.4.2.2. Germany Market, By End-User, 2021-2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021-2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By Type, 2021-2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021-2030 (USD Million) 9.2.4.3.3. France Market, By End-User, 2021-2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By Type, 2021-2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021-2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, By End-User, 2021-2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By Type, 2021-2030 (USD Million) 9.3.2. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021-2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By Type, 2021-2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021-2030 (USD Million) 9.3.4.1.3. China Market, By End-User, 2021-2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By Type, 2021-2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021-2030 (USD Million) 9.3.4.2.3. India Market, By End-User, 2021-2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By Type, 2021-2030 (USD Million) 9.3.4.3.3. Japan Market, By End-User, 2021-2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By Type, 2021-2030 (USD Million) 9.3.4.4.3. South Korea Market, By End-User, 2021-2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By Type, 2021-2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By Type, 2021-2030 (USD Million) 9.4.3. Latin America Market, By End-User, 2021-2030 (USD Million) 9.4.4. Latin America Market, by country, 2021-2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By Type, 2021-2030 (USD Million) 9.4.4.1.3. Brazil Market, By End-User, 2021-2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By Type, 2021-2030 (USD Million) 9.4.4.2.3. Mexico Market, By End-User, 2021-2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin American market, By Type, 2021-2030 (USD Million) 9.4.4.3.3. Rest of the Latin American market, By End-User, 2021-2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By Type, 2021-2030 (USD Million) 9.5.3. MEA Market, By End-User, 2021-2030 (USD Million) 10. Competitive Landscape 10.1 Medtronic. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Stryker Corporation. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. DePuy Synthes. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. LLC 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Globus Medical, Inc. 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Zimmer Biomet Holdings, Inc. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. NuVasive, Inc 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Paradigm Spine. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development List of Tables (39 Tables) TABLE 1. Market, By Type, 2021-2030 (USD Million) TABLE 2. Market FOR Artificial disc replacement device, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Partial disc (nucleus) replacement device, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Dynamic stabilization devices, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Total disc replacement devices, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Annulus repair device, BY REGION, 2021-2030 (USD Million) TABLE 7. Market, BY END-USER, 2021-2030 (USD Million) TABLE 8. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Specialty Clinics, BY REGION, 2021-2030 (USD Million) TABLE 10. Market, BY REGION, 2021-2030 (USD Million) TABLE 11. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, By End-Users, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, By Type, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, BY END-USER, 2021-2030 (USD Million) TABLE 15. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 16. EUROPE Market, By Type, 2021-2030 (USD Million) TABLE 17. EUROPE Market, BY END-USER, 2021-2030 (USD Million) TABLE 18. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 19. ASIA-PACIFIC Market, By Type, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY END-USER, 2021-2030 (USD Million) TABLE 21. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. LAMEA Market, By Type, 2021-2030 (USD Million) TABLE 23. LAMEA Market, BY END-USER, 2021-2030 (USD Million) TABLE 24. Medtronic: COMPANY SNAPSHOT TABLE 25. Medtronic: OPERATING SEGMENTS TABLE 26. Stryker Corporation: COMPANY SNAPSHOT TABLE 27. Stryker Corporation: OPERATING SEGMENTS TABLE 28. DePuy Synthes: COMPANY SNAPSHOT TABLE 29. DePuy Synthes: OPERATING SEGMENTS TABLE 30. LLC: COMPANY SNAPSHOT TABLE 31. LLC: OPERATING SEGMENTS TABLE 32. Globus Medical, Inc.: COMPANY SNAPSHOT TABLE 33. Globus Medical, Inc.: OPERATING SEGMENTS TABLE 34. Zimmer Biomet Holdings, Inc: COMPANY SNAPSHOT TABLE 35. Zimmer Biomet Holdings, Inc: OPERATING SEGMENTS TABLE 36. NuVasive, Inc: COMPANY SNAPSHOT TABLE 37. NuVasive, Inc: OPERATING SEGMENTS TABLE 38. Paradigm Spine: COMPANY SNAPSHOT TABLE 39. Paradigm Spine: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 8 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Spinal Non-Fusion Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Spinal Non-Fusion Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11Market, By End-Users, 2019 vs. 2025 (USD Million) Figure 12Market Share, By Type, 2019 vs. 2025 Figure 13 Geographical Snapshot of the Market Figure 14 Dynamic stabilization devices to Witness Higher CAGR in the Market for Type Segment During the Forecast Period. Figure 15 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 16 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview